<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT2017010231722N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2017-04-10</date_registration>
      <primary_sponsor>Vice chancellor for reaserch, Iran University of Medical Science</primary_sponsor>
      <public_title>Comparison of the efficacy of capsule of “ Golnar”  and Placebo on heavy menstural bleeding: A double- blind randomized clinical trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the efficacy of capsule of “ Golnar”  and Placebo on heavy menstural bleeding in 20- 40 years women: A double- blind randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>88</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/24896</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: This is the double-blind study: participants and researchers do not know the type of drug or placebo was administered. Participants by Block Randomization will be divided into two groups.Then the drug and placebo accordance with the table are placed randomly in the hands of participants.</study_design>
      <phase>2</phase>
      <hc_freetext>MENSTURAL BLEEDING.</hc_freetext>
      <i_freetext>Intervention 1: Intervention 1.A 500-mg capsules Golnar 20 minutes after each meal for three menstrual cycles during the 7 days will be spent. Intervention 2: Intervention 2. A 500 mg capsules containing bread powder 20 minutes after each meal  for three menstrual cycles during the 7 days will be spent.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hashem Dabaghian Fataneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Traditional Medicine, Behesht Street, Vahdat Islami Street, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 5563 9724</telephone>
        <email>Fataneh.Dabaghian@yahoo.com</email>
        <affiliation>Iran University of Medical Science- Traditional Medicine School</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hashem Dabaghian Fataneh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Traditional Medicine, Behesht Street, vahdat islami street, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 21 5563 9724</telephone>
        <email>fataneh.dabaghian@yahoo.com</email>
        <affiliation>Iran university of science- Traditional medicine school</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:&#13;
• Informed written consent of patients&#13;
• Age 40-20 years&#13;
• Has bleeding more than 7 days&#13;
• More than 80 cc blood loss (see  Hygam chart )&#13;
• Endometrial thickness in ultrasound is normal which is equal to or less than 12 mm&#13;
• Gynecological examination is normal&#13;
• Pap smear results are normal&#13;
• Patient has Hb≥11&#13;
&#13;
Exclusion criteria:&#13;
• Hemoglobin high level of 16&#13;
• Bleeding is so severe that emergency measures needed&#13;
• Plan to become pregnant in the next three months&#13;
• Catching Systemic or Pelvic inflammatory disease&#13;
• Catching chronic diseases such as diabetes, lupus and thyroid problems&#13;
• Catching Organic diseases such as cancer of the Uterus or ovaries or other malignancies&#13;
• Conjugation of any herbal remedies or certain chemicals that interfere with the study drug or have an impact on menstrual bleeding Such as birth control pills containing estrogen and progesterone or just progestin &#13;
• Pregnancy and lactation&#13;
• Catching Known hyperprolactinemia&#13;
• Catching sub-mucosal or intramural fibroids which are larger than 5 cm&#13;
• The patient has no wish to consume these types of drugs</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>40 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N92.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Excessive and frequent menstruation with regular cycle</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention 1.A 500-mg capsules Golnar 20 minutes after each meal for three menstrual cycles during the 7 days will be spent.</i_keyword>
      <i_keyword>Intervention 2. A 500 mg capsules containing bread powder 20 minutes after each meal  for three menstrual cycles during the 7 days will be spent.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Bleeding volume. Timepoint: before and 3 month after intervention. Method of measurement: Higam chart(PBAC Questionaire).</prim_outcome>
      <prim_outcome>Duration of bleeding. Timepoint: before and 3 month after intervention. Method of measurement: Questionaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Hemoglobin concentration. Timepoint: Before the intervention, and at the end of each menstrual cycle. Method of measurement: Hemiglobincyanide method, Hemoglobin measuring kit.</sec_outcome>
      <sec_outcome>Potential drug side effects. Timepoint: end of intervention. Method of measurement: Questionaire.</sec_outcome>
      <sec_outcome>Quality of life. Timepoint: Before and the end of intervention. Method of measurement: Menorrhagia Questionaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name>Research Institute for Islamic and Complementary Medicine/ Iran University of medical science</sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Vice chancellor for reaserch, Iran University of Medical Science</source_name>
      <source_name>Research Institute for Islamic and Complementary Medicine/ Iran University of medical science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-12-27</approval_date>
        <contact_name>Ethics Commitee of Iran University of Medical Science</contact_name>
        <contact_address>Iran University of Medical Science, Besides Milad Tower, Hemmat Highway, Tehran Tehran  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
